GlassScriptPhysician profile
Rachelle Vanmeter
NPI 1316467442
$796.18
in general payments reported to CMS, 2019-2025
15 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $279 · 2022: $33.92 · 2023: $104 · 2024: $232 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.36 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $219.80 | 2021-2024 | Ova1 |
| Abbvie INC. | $198.51 | 2021-2022 | |
| Biogen, INC. | $66.00 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $47.76 | 2023-2025 | Veozah |
| Pfizer INC. | $41.96 | 2021-2024 | |
| Exeltis, USA INC. | $35.14 | 2025 | Slynd |
| Csl Behring | $34.74 | 2023 | Haegarda |
| Millicent US INC | $26.70 | 2023 | Femring |
| Bayer Healthcare Pharmaceuticals INC. | $24.78 | 2025 | |
| Hologic Sales and Service, LLC | $19.12 | 2023 | Aptima |
| Mayne Pharma Commercial LLC | $18.97 | 2021 | |
| Organon LLC | $18.29 | 2024 | |
| Optumhealth Care Solutions, LLC | $15.86 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Pharmacosmos Therapeutics INC. | $15.85 | 2021 | |
| Myovant Sciences INC. | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachelle Vanmeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.